| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 7265 | 2008 |
| Levodopa and the progression of Parkinson's disease Parkinson Study Group New England Journal of Medicine 351 (24), 2498-2508, 2004 | 2388 | 2004 |
| Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial Parkinson Study Group, Parkinson Study Group Jama 284 (15), 1931-1938, 2000 | 1119 | 2000 |
| Practice parameter: Treatment of parkinson disease with motor fluctuations and dyskinesia (an evidence-based review):[retired] report of the quality standards subcommittee of … R Pahwa, SA Factor, KE Lyons, WG Ondo, G Gronseth, H Bronte-Stewart, ... Neurology 66 (7), 983-995, 2006 | 760 | 2006 |
| A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study Parkinson Study Group Archives of neurology 59 (12), 1937-1943, 2002 | 731 | 2002 |
| Effect of GPi pallidotomy on motor function in Parkinson's disease AM Lozano, AE Lang, N Galvez-Jimenez, J Miyasaki, J Duff, ... The Lancet 346 (8987), 1383-1387, 1995 | 728 | 1995 |
| Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review):[RETIRED] Report of the Quality Standards … JM Miyasaki, K Shannon, V Voon, B Ravina, G Kleiner-Fisman, ... Neurology 66 (7), 996-1002, 2006 | 703 | 2006 |
| Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. RG Holloway, I Shoulson, S Fahn, K Kieburtz, A Lang, K Marek, ... Archives of neurology 61 (7), 1044-1053, 2004 | 697 | 2004 |
| Practice parameter: initiation of treatment for Parkinson’s disease: an evidence-based review JM Miyasaki, W Martin, O Suchowersky, WJ Weiner, AE Lang Neurology 58 (1), 11-17, 2002 | 600 | 2002 |
| Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease D Weintraub, S Hoops, JA Shea, KE Lyons, R Pahwa, ... Movement disorders: official journal of the Movement Disorder Society 24 (10 …, 2009 | 586 | 2009 |
| Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study TDL Steeves, J Miyasaki, M Zurowski, AE Lang, G Pellecchia, ... Brain 132 (5), 1376-1385, 2009 | 565 | 2009 |
| Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review)[RETIRED] Report of the Therapeutics and Technology Assessment Subcommittee … DM Simpson, A Blitzer, A Brashear, C Comella, R Dubinsky, M Hallett, ... Neurology 70 (19), 1699-1706, 2008 | 554 | 2008 |
| Prevalence of repetitive and reward-seeking behaviors in Parkinson disease V Voon, K Hassan, M Zurowski, M De Souza, T Thomsen, S Fox, AE Lang, ... Neurology 67 (7), 1254-1257, 2006 | 537 | 2006 |
| A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease C Zadikoff, SH Fox, DF Tang‐Wai, T Thomsen, RMA De Bie, P Wadia, ... Movement disorders 23 (2), 297-299, 2008 | 533 | 2008 |
| Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review):[RETIRED] Report of the Therapeutics and Technology Assessment Subcommittee of the … DM Simpson, JM Gracies, HK Graham, JM Miyasaki, M Naumann, ... Neurology 70 (19), 1691-1698, 2008 | 498 | 2008 |
| Factors associated with dopaminergic drug–related pathological gambling in Parkinson disease V Voon, T Thomsen, JM Miyasaki, M de Souza, A Shafro, SH Fox, ... Archives of Neurology 64 (2), 212-216, 2007 | 417 | 2007 |
| Prospective prevalence of pathologic gambling and medication association in Parkinson disease V Voon, K Hassan, M Zurowski, S Duff-Canning, M De Souza, S Fox, ... Neurology 66 (11), 1750-1752, 2006 | 414 | 2006 |
| Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease [RETIRED] Report of the Quality Standards Subcommittee of the American Academy of Neurology TA Zesiewicz, KL Sullivan, I Arnulf, KR Chaudhuri, JC Morgan, ... Neurology 74 (11), 924-931, 2010 | 372 | 2010 |
| Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice A Keller, A Westenberger, MJ Sobrido, M Garcia-Murias, A Domingo, ... Nature genetics 45 (9), 1077-1082, 2013 | 333 | 2013 |
| Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis [RETIRED] Report of the Therapeutics and Technology Assessment … JJ Marriott, JM Miyasaki, G Gronseth, PW O'Connor Neurology 74 (18), 1463-1470, 2010 | 322 | 2010 |
Anthony E LangUniversity of TorontoEmail confirmado em uhnres.utoronto.ca